Research ExplorerResearch UnitsDepartment for Urology Publications

Department for Urology

1801 - 1850 out of 1,860Page size: 50

Publications

  1. 2003

  2. Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables.

    Graefen, M., Augustin, H., Karakiewicz, P. I., Hammerer, P. G., Haese, A., Palisaar, J., Blonski, J., Fernandez, S., Erbersdobler, A. & Huland, H., 2003, In: EUR UROL. 43, 1, p. 6-11 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer.

    Friedrich, M., Toma, M. I., Hellstern, A., Pantel, K., Weisenberger, D. J., Noldus, J. & Huland, H., 2003, In: BJU INT. 92, 9, p. 911-914 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Cyclooxygenase-2 promotes angiogenesis in pTa/T1 urothelial bladder carcinoma but does not predict recurrence.

    Friedrich, M., Toma, M. I., Petri, S. & Huland, H., 2003, In: BJU INT. 92, 4, p. 389-392 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Differences in biopsy features between prostate cancers located in the transition and peripheral zone.

    Augustin, H., Erbersdobler, A., Graefen, M., Jaekel, T., Haese, A., Huland, H. & Hammerer, P. G., 2003, In: BJU INT. 91, 6, p. 477-481 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Evaluation of renal growth by magnetic resonance imaging and computerized tomography volumes.

    Heuer, R., Sommer, G. & Shortliffe, L. D., 2003, In: J UROLOGY. 170, 4 Pt 2, p. 1659-1663 4 Pt 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. [Indications for and results of radical prostatectomy]

    Graefen, M., Hammerer, P. G., Haese, A. & Huland, H., 2003, In: UROLOGE. 42, 9, p. 1203-1211 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study.

    Haese, A., Chaudhari, M., Miller, M. C., Epstein, J. I., Huland, H., Palisaar, J., Graefen, M., Hammerer, P., Poole, E. C., O'Dowd, G. J., Partin, A. W. & Veltri, R. W., 2003, In: CANCER-AM CANCER SOC. 97, 4, p. 969-978 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. [Serum markers for early detection and staging of prostate cancer. Status report on current and future markers]

    Haese, A., Graefen, M., Palisaar, J., Huland, E. & Huland, H., 2003, In: UROLOGE. 42, 9, p. 1172-1187 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Standardization of two immunoassays for human glandular kallikrein 2.

    Haese, A., Vaisanen, V., Finlay, J. A., Pettersson, K., Rittenhouse, H. G., Partin, A. W., Bruzek, D. J., Sokoll, L. J., Lilja, H. & Chan, D. W., 2003, In: CLIN CHEM. 49, 4, p. 601-610 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.

    Haese, A., Graefen, M., Becker, C., Noldus, J., Katz, J., Cagiannos, I., Kattan, M., Scardino, P. T., Huland, E., Huland, H. & Lilja, H., 2003, In: PROSTATE. 54, 3, p. 181-186 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.

    Haese, A., Graefen, M., Steuber, T., Becker, C., Noldus, J., Erbersdobler, A., Huland, E., Huland, H. & Lilja, H., 2003, In: J UROLOGY. 170(6 Pt 1), p. 2269-2273

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Total, free and complexed PSA and hK2 for early detection of prostate cancer.

    Haese, A., Khan, M. A. & Sokoll, L. J., 2003, In: MLO Med Lab Obs. 35, 6, p. 14-16, 20, 30-31 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. [Transrectal ultrasound-guided punch biopsies of the prostate. Indication, technique, results, and complications]

    Palisaar, J., Eggert, T., Graefen, M., Haese, A. & Huland, H., 2003, In: UROLOGE. 42, 9, p. 1188-1195 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. 2002

  16. Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?

    Cagiannos, I., Graefen, M., Karakiewicz, P. I., Ohori, M., Eastham, J. A., Rabbani, F., Fair, W., Wheeler, T. M., Hammerer, P. G., Haese, A., Erbersdobler, A., Huland, H., Scardino, P. T. & Kattan, M. W., 2002, In: J CLIN ONCOL. 20, 8, p. 2025-2030 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.

    Palisaar, R. J., Graefen, M., Karakiewicz, P. I., Hammerer, P. G., Huland, E., Haese, A., Fernandez, S., Erbersdobler, A., Henke, R-P. & Huland, H., 2002, In: EUR UROL. 41, 2, p. 155-161 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.

    Graefen, M., Karakiewicz, P. I., Cagiannos, I., Hammerer, P. G., Haese, A., Palisaar, J., Fernandez, S., Noldus, J., Erbersdobler, A., Huland, H., Scardino, P. T. & Kattan, M. W., 2002, In: UROL ONCOL-SEMIN ORI. 7, 4, p. 141-146 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Characterization of cells prepared by dendritic cell-tumor cell fusion.

    Gottfried, E., Krieg, R., Eichelberg, C., Andreesen, R., Mackensen, A. & Krause, S. W., 2002, In: Cancer Immun. 2, p. 15

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Clinical evaluation of the Elecsys total prostate-specific antigen assay on the Elecsys 1010 and 2010 systems.

    Haese, A., Dworschack, R. T., Piccoli, S. P., Sokoll, L. J., Partin, A. W. & Chan, D. W., 2002, In: CLIN CHEM. 48(6 Pt 1), p. 944-947

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests.

    Friedrich, M., Hellstern, A., Hautmann, S. H., Graefen, M., Conrad, S., Huland, E. & Huland, H., 2002, In: J UROLOGY. 168, 2, p. 470-474 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.

    Steuber, T., Nurmikko, P., Haese, A., Pettersson, K., Graefen, M., Hammerer, P., Huland, H. & Lilja, H., 2002, In: J UROLOGY. 168, 5, p. 1917-1922 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.

    Graefen, M., Karakiewicz, P. I., Cagiannos, I., Quinn, D. I., Henshall, S. M., Grygiel, J. J., Sutherland, R. L., Stricker, P. D., Klein, E., Kupelian, P., Skinner, D. G., Lieskovsky, G., Bochner, B., Huland, H., Hammerer, P. G., Haese, A., Erbersdobler, A., Eastham, J. A., de Kernion, J., Cangiano, T., Schröder, F. H., Wildhagen, M. F., Kwast, V. D., Theo, H., Scardino, P. T. & Kattan, M. W., 2002, In: J CLIN ONCOL. 20, 15, p. 3206-3212 15.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy.

    Noldus, J., Michl, U., Graefen, M., Haese, A., Hammerer, P. & Huland, H., 2002, In: EUR UROL. 42, 2, p. 118-124 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.

    Haese, A., Dworschack, R. T. & Partin, A. W., 2002, In: J UROLOGY. 168, 2, p. 504-508 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.

    Graefen, M., Karakiewicz, P. I., Cagiannos, I., Hammerer, P. G., Haese, A., Palisaar, J., Huland, E., Scardino, P. T., Kattan, M. W. & Huland, H., 2002, In: J UROLOGY. 167, 3, p. 1306-1309 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Prediction of tumor heterogeneity in localized prostate cancer.

    Huland, H., Graefen, M., Haese, A., Hammerer, P. G., Palisaar, J., Pichlmeier, U., Henke, R-P., Erbersdobler, A., Huland, E. & Lilja, H., 2002, In: UROL CLIN N AM. 29, 1, p. 213-222 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction.

    Stephan, M., Conrad, S., Eggert, T., Heuer, R., Fernandez, S. & Huland, H., 2002, In: J UROLOGY. 167, 3, p. 1497-1502 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma.

    Haese, A., Epstein, J. I., Huland, H. & Partin, A. W., 2002, In: CANCER-AM CANCER SOC. 95, 5, p. 1016-1021 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. 2001

  31. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy.

    Graefen, M., Haese, A., Pichlmeier, U., Hammerer, P. G., Noldus, J., Butz, K., Erbersdobler, A., Henke, R. P., Michl, U., Fernandez, S. & Huland, H., 2001, In: J UROLOGY. 165, 3, p. 857-863 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer.

    Hautmann, S. H., Lokeshwar, V. B., Schroeder, G. L., Civantos, F., Duncan, R. C., Gnann, R., Friedrich, M. & Soloway, M. S., 2001, In: J UROLOGY. 165(6 Pt 1), p. 2068-2074

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.

    Friedrich, M., Blind, C., Milde-Langosch, K., Erbersdobler, A., Conrad, S., Löning, T., Hammerer, P. & Huland, H., 2001, In: EUR UROL. 40, 5, p. 518-524 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.

    Haese, A., Graefen, M., Steuber, T., Becker, C., Pettersson, K., Piironen, T., Noldus, J., Huland, H. & Lilja, H., 2001, In: PROSTATE. 49, 2, p. 101-109 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. [Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]

    Hautmann, S. H., Schroeder, G. L., Civantos, F., Duncan, R. C., Gnann, R., Friedrich, M., Hellstern, A., Huland, H., Soloway, M. S. & Lokeshwar, V. B., 2001, In: UROLOGE. 40, 2, p. 121-126 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. [Nerve-sparing radical retropubic prostatectomy. Results of a patient survey]

    Noldus, J., Michl, U., Graefen, M., Haese, A., Hammerer, P., Fernandez, S. & Huland, H., 2001, In: UROLOGE. 40, 2, p. 102-106 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. New serum tests for the diagnosis of prostate cancer.

    Haese, A. & Partin, A., 2001, In: DRUG TODAY. 37, 9, p. 607-616 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Nitric oxide activates the beta 2 subunit of soluble guanylyl cyclase in the absence of a second subunit.

    Koglin, M., Vehse, K., Budäus, L., Scholz, H. & Behrends, S., 2001, In: J BIOL CHEM. 276, 33, p. 30737-30743 33.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder.

    Friedrich, M., Riethdorf, S., Erbersdobler, A., Tiemer, C., Schwaibold, H., Sölter, J. K., Huland, E., Riethdorf, L., Conrad, S., Hammerer, P. G. & Huland, H., 2001, In: EUR UROL. 39, 2, p. 159-166 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. The beta 2 subunit of nitric oxide-sensitive guanylyl cyclase is developmentally regulated in rat kidney.

    Behrends, S., Budäus, L., Kempfert, J., Scholz, H., Starbatty, J. & Vehse, K., 2001, In: N-S ARCH PHARMACOL. 364, 6, p. 573-576 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. 2000

  42. Analysis of molecular isoforms of PSA and their ratios in men with PSA-relapse after radical prostatectomy.

    Hammerer, P., Graefen, M., Henke, R. P., Haese, A., Palisaar, J., Huland, E. & Huland, H., 2000, In: ANTICANCER RES. 20, 6, p. 5253-5255 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. [Chemoprevention of prostatic carcinoma]

    Hammerer, P., Graefen, M., Steuber, T. & Huland, H., 2000, In: UROLOGE. 39, 4, p. 304-308 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.

    Friedrich, M., Erbersdobler, A., Schwaibold, H., Conrad, S., Huland, E. & Huland, H., 2000, In: J UROLOGY. 163, 3, p. 1039-1042 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.

    Haese, A., Becker, C., Noldus, J., Graefen, M., Huland, E., Huland, H. & Lilja, H., 2000, In: J UROLOGY. 163, 5, p. 1491-1497 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. [Mucinous adenocarcinoma of the urachus. Case report and review of the literature]

    Reek, C., Graefen, M., Erbersdobler, A. & Haese, A., 2000, In: UROLOGE. 39, 6, p. 572-575 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. [Prognostic markers for prostate cancer]

    Graefen, M., Hammerer, P., Noldus, J., Haese, A., Pichelmeier, U., Erbersdobler, A., Henke, H., Conrad, S., Fernandez, S. & Huland, H., 2000, In: UROLOGE. 39, 1, p. 14-21 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Ratio free/total PSA (%f-PSA) in men with total PSA 0.5-3 ng/ml: improvement for prostate cancer detection?

    Hammerer, P., Graefen, M., Henke, R. P., Haese, A., Huland, E. & Huland, H., 2000, In: PROSTATE CANCER P D. 3, 1, p. 19 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Stage migration in clinically localized prostate cancer.

    Noldus, J., Graefen, M., Haese, A., Henke, R. P., Hammerer, P. & Huland, H., 2000, In: EUR UROL. 38, 1, p. 74-78 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Super-sensitive prostate-specific antigen (PSA) in serum of women with benign breast disease or breast cancer.

    Hautmann, S., Huland, E., Grupp, C., Haese, A. & Huland, H., 2000, In: ANTICANCER RES. 20, 3, p. 2151-2154 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. The correction of penile curvature with the Essed-Schröder technique: a long-term follow-up assessing functional aspects and quality of life.

    Friedrich, M., Evans, D., Noldus, J. & Huland, H., 2000, In: BJU INT. 86, 9, p. 1034-1038 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. [Therapeutic options in hormone refractory prostate carcinoma]

    Graefen, M., Hammerer, P., Haese, A. & Huland, H., 2000, In: UROLOGE. 39, 3, p. 267-273 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Treatment of metastatic hormone-refractory prostate adenocarcinoma (MatLyLu) in Copenhagen rats with micro-osmotic interleukin-2 pumps.

    Hautmann, S., Huland, E., Wullbrand, A., Friedrich, M. & Huland, H., 2000, In: ANTICANCER RES. 20, 6, p. 4495-4498 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. 1999

  55. Subjective and objective prospective, long-term analysis of quality of life during inhaled interleukin-2 immunotherapy

    Heinzer, H., Mir, T. S., Huland, E. & Huland, H., 11.1999, In: J CLIN ONCOL. 17, 11, p. 3612-3620 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...33 34 35 36 37 38 Next